NFKB1 and cancer: Such inhibition results in holding the NFκB in the cytoplasm, which prevents NFκB’s translocation to the nucleus where it would otherwise activate the transcription of genes involved in cancer inflammation, cell proliferation, and survival [127] (Figure 2).